Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA HERPES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 VIRUS TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SUMMARY WRITE UP (NORTH AMERICA)
4.1.1 OVERVIEW
4.2 SUMMARY WRITE UP (EUROPE)
4.2.1 OVERVIEW
4.3 SUMMARY WRITE UP (ASIA-PACIFIC)
4.3.1 OVERVIEW
4.4 SUMMARY WRITE UP (SOUTH AMERICA)
4.4.1 OVERVIEW
4.5 SUMMARY WRITE UP (MIDDLE EAST AND AFRICA)
4.5.1 OVERVIEW
5 NORTH AMERICA HERPES MARKET: REGULATIONS
5.1 THE U.S. REGULATORY FRAMEWORK
5.2 CANADA REGULATORY FRAMEWORK
5.3 THE EUROPE REGULATORY FRAMEWORK
5.4 INDIA REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.2 INCREASING GERIATRIC POPULATION
6.2.1 INCREASE IN PREVALENCE OF HERPES INFECTIONS
6.2.2 INCREASE IN NUMBER OF PRODUCT APPROVALS AND LAUNCHES
6.2.3 RISING NUMBER OF IMMUNOCOMPROMISED PEOPLE
6.3 RESTRAINTS
6.3.1 HIGH COST OF ANTI-HERPETIC MEDICINES
6.3.2 PRODUCT RECALL
6.4 OPPORTUNITIES
6.4.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
6.4.2 INCREASING HEALTHCARE EXPENDITURE
6.4.3 SOARING NUMBER OF ANTI-HERPETIC DRUGS MANUFACTURERS
6.4.4 RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (CRO)
6.5 CHALLENGES
6.5.1 DISRUPTION IN THE SUPPLY CHAIN OF HERPES DRUGS AND INJECTIONS DURING COVID-19
6.5.2 LACK OF WORKFORCE IN PHARMA INDUSTRIES
7 IMPACT OF COVID-19 ON NORTH AMERICA HERPES MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISION BY MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA HERPES MARKET, BY VIRUS TYPE
8.1 OVERVIEW
8.2 HERPES SIMPLEX
8.2.1 TYPE I
8.2.2 TYPE II
8.3 HERPES ZOSTER
9 NORTH AMERICA HERPES MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 ACYCLOVIR
9.3 DOCOSANOL
9.4 VALACYCLOVIR
9.5 FAMCICLOVIR
9.6 OTHERS
10 NORTH AMERICA HERPES MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 PRESCRIPTION DRUG
10.3 OVER-THE COUNTER DRUG
11 NORTH AMERICA HERPES MARKET, BY AGE
11.1 OVERVIEW
11.2 ADULT
11.3 PEDIATRICS
12 NORTH AMERICA HERPES MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 TOPICAL
12.3 ORAL
12.4 PARENTERAL
13 NORTH AMERICA HERPES MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 HOSPITALS PHARMACIES
13.3 RETAIL PHARMACIES
13.4 DRUG STORES
13.5 ONLINE PHARMACIES
13.6 OTHERS
14 NORTH AMERICA HERPES MARKET, BY END USERS
14.1 OVERVIEW
14.2 HOSPITALS
14.3 SPECIALITY CLINICS
14.4 OTHERS
15 NORTH AMERICA HERPES MARKET, BY REGION
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
16 NORTH AMERICA HERPES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 GLAXOSMITHKILNE PLC
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENT
18.2 VIATRIS INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENT
18.3 FRESENIUS KABI AG
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 PFIZER INC.
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENT
18.6 ABBOTT
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENT
18.7 AMNEAL PHARMACEUTICALS LLC
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENTS
18.8 APOTEX INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPMENT
18.1 AVET PHARMACEUTICALS INC.
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 BAUSCH HEALTH COMPANIES INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENT
18.12 BLISTEX, INC.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 CIPLA, INC.
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 DR. REDDY’S LABORATORIES LTD.
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENT
18.15 EPIHEALTH
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 GLENMARK PHARMACEUTICAL INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICALS LTD.)
18.16.1 COMPANY SNAPSHOT
18.16.2 REVENUE ANALYSIS
18.16.3 PRODUCT PORTFOLIO
18.16.4 RECENT DEVELOPMENT
18.17 MARUHO CO.,LTD.
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENTS
18.18 RECORDATI S.P.A.
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 SLAVIA PHARM S.R.L.
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.2 SUN PHARMACEUTICAL INDUSTRIES LTD
18.20.1 COMPANY SNAPSHOT
18.20.2 REVENUE ANALYSIS
18.20.3 PRODUCT PORTFOLIO
18.20.4 RECENT DEVELOPMENT
18.21 ZYDUS PHARMACEUTICALS, INC.
18.21.1 COMPANY SNAPSHOT
18.21.2 PRODUCT PORTFOLIO
18.21.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 THE EMA HAS SEVEN SCIENTIFIC COMMITTEES THAT CARRY OUT ITS SCIENTIFIC ASSESSMENTS:
TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 3 MANUFACTURERS OF ANTI-HERPETIC DRUGS
TABLE 4 NORTH AMERICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA HERPES SIMPLEX IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA HERPES ZOSTER IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA ACYCLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA DOCOSANOL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA VALACYCLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA FAMCICLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA PRESCRIPTION DRUG IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA OVER-THE COUNTER DRUG IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA ADULT IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA PEDIATRICS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA TOPICAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA ORAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA PARENTERAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA HOSPITALS PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA RETAIL PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA DRUG STORES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA ONLINE PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA HOSPITALS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA SPECIALITY CLINICS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA HERPES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 43 U.S. HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 44 U.S. HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 45 U.S. HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 46 U.S. HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 47 U.S. HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 48 U.S. HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 49 U.S. HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 U.S. HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 51 CANADA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 52 CANADA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 53 CANADA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 54 CANADA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 55 CANADA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 56 CANADA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 57 CANADA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 58 CANADA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
TABLE 59 MEXICO HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 60 MEXICO HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)
TABLE 61 MEXICO HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 62 MEXICO HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 63 MEXICO HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)
TABLE 64 MEXICO HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 65 MEXICO HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 66 MEXICO HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 NORTH AMERICA HERPES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA HERPES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA HERPES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA HERPES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA HERPES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA HERPES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA HERPES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA HERPES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA HERPES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA HERPES MARKET: SEGMENTATION
FIGURE 11 INCREASE IN PREVALENCE OF HERPES INFECTIONS AND RISE IN HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE NORTH AMERICA HERPES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 HERPES SIMPLEX SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA HERPES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA HERPES MARKET
FIGURE 14 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS IN 2020 (IN MILLIONS)
FIGURE 15 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)
FIGURE 16 NORTH AMERICA HERPES MARKET : BY VIRUS TYPE, 2020
FIGURE 17 NORTH AMERICA HERPES MARKET : BY VIRUS TYPE, 2019-2028 (USD MILLION)
FIGURE 18 NORTH AMERICA HERPES MARKET : BY VIRUS TYPE, CAGR (2021-2028)
FIGURE 19 NORTH AMERICA HERPES MARKET : BY VIRUS TYPE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA HERPES MARKET : BY PRODUCT TYPE, 2020
FIGURE 21 NORTH AMERICA HERPES MARKET : BY PRODUCT TYPE, 2019-2028 (USD MILLION)
FIGURE 22 NORTH AMERICA HERPES MARKET : BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 23 NORTH AMERICA HERPES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 NORTH AMERICA HERPES MARKET : BY DRUG TYPE, 2020
FIGURE 25 NORTH AMERICA HERPES MARKET : BY DRUG TYPE, 2019-2028 (USD MILLION)
FIGURE 26 NORTH AMERICA HERPES MARKET : BY DRUG TYPE, CAGR (2021-2028)
FIGURE 27 NORTH AMERICA HERPES MARKET : BY DRUG TYPE, LIFELINE CURVE
FIGURE 28 NORTH AMERICA HERPES MARKET: BY AGE, 2020
FIGURE 29 NORTH AMERICA HERPES MARKET: BY AGE, 2019-2028 (USD MILLION)
FIGURE 30 NORTH AMERICA HERPES MARKET: BY AGE, CAGR (2021-2028)
FIGURE 31 NORTH AMERICA HERPES MARKET: BY AGE, LIFELINE CURVE
FIGURE 32 NORTH AMERICA HERPES MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 33 NORTH AMERICA HERPES MARKET: BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
FIGURE 34 NORTH AMERICA HERPES MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2021-2028)
FIGURE 35 NORTH AMERICA HERPES MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 36 NORTH AMERICA HERPES MARKET: DISTRIBUTION CHANNEL, 2020
FIGURE 37 NORTH AMERICA HERPES MARKET: DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 38 NORTH AMERICA HERPES MARKET: DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 NORTH AMERICA HERPES NORTH AMERICA MARKET: DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 NORTH AMERICA HERPES MARKET: BY END USERS, 2020
FIGURE 41 NORTH AMERICA HERPES MARKET: BYEND USERS, 2019-2028 (USD MILLION)
FIGURE 42 NORTH AMERICA HERPES MARKET: BY END USERS, CAGR (2021-2028)
FIGURE 43 NORTH AMERICA HERPES MARKET: BY END USERS, LIFELINE CURVE
FIGURE 44 NORTH AMERICA HERPES MARKET: SNAPSHOT (2020)
FIGURE 45 NORTH AMERICA HERPES MARKET: BY COUNTRY (2020)
FIGURE 46 NORTH AMERICA HERPES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 47 NORTH AMERICA HERPES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 NORTH AMERICA HERPES MARKET: BY VIRUS TYPE (2021-2028)
FIGURE 49 NORTH AMERICA HERPES MARKET: COMPANY SHARE 2020 (%)
